According to a new study, the use of hydroxychloroquine drastically reduces the death rate of those infected with coronavirus.
The Henry Ford Health System conducted a study that analyzed 2,541 patients who had been hospitalized in six hospitals May 10-22. The research center found that the use of the controversial drug touted by President Trump as a possible treatment for the virus undoubtedly "helped save lives."
"Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19," the Henry Ford Health System said in a statement. "As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients."
The mortality rates of the study are as follows:
- Crude mortality rate - 18.1%
- Hydroxychloroquine alone - 13.5%
- Hydroxychloroquine plus azithromycin - 20.1%
- Azithromycin alone - 22.4%
- Neither drug - 26.4%
Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, said the study revealed that the timing of administering hydroxychloroquine was an important factor.
"For hydroxychloroquine to have a benefit, it needs to be given before the patient suffers some of the severe immune reactions that can occur with COVID," Zervos said.
Although the Henry Ford medical team was aware of reported heart-related side effects when using hydroxychloroquine, none of the patients in the new study experienced such side effects.